International Conference on

Cancer Immunotherapy

Cancer Immunotherapy 2022

Theme: Research ChallengesAdvancements in Cancer and Therapeutic Strategies

Meetings International invites participants from all over the globe to attend the “International Conference on Cancer Immunotherapy” during May 18-19, 2022 at Amsterdam, Netherlands. which gathers all the people to share their knowledge and have a discussion on the current issue on Cancer and development of Cancer therapies.  The theme “Research Challenges & Advancements in Cancer and Therapeutic Strategies”. The Conference expertise meet in the field of Oncology where oncologists, scientists, researchers, medical students, pharmacists, R&D scholars, medical professors, gynecologists, molecular biologists, bioinformatics students and professors, radiologists, Cancer research institutes to exchange ideas, communicate & discuss the research work and about new advancements in the Cancer therapy and treatment.

 

Cancer-Immunotherapy -2022 is aimed the World's leading technical Conferences. The two days event on Cancer-Immunotherapy will host 20+ Scientific and technical sessions and sub-sessions on leading and latest research transformation related to the field, covering the globe. Cancer-Immunotherapy Conference 2022 will comprise of 10 major sessions designed to offer comprehensive sessions that discourse current topics in the field. The attendees can find exclusive sessions and panel discussions on the latest innovations in Cancer-Immunotherapy by:

  • Lectures from renowned speakers
  • Keynote forums by Prominent Professors, Eminent Researchers
  • Open Innovation Challenges
  • Poster presentations by Young Researchers
  • Global Networking sessions with 30+ Countries
  • Novel techniques to benefit your research
  • Best platform for Global business and Networking opportunities
  • Meet the editors of refereed journals, Society and Association members across the Globe
  • Excellent platform to showcase the latest innovation and concept in the technical field.

 

  • Cancer Immunotherapy/Research Professors
  • Junior/Senior research fellows of Cancer Immunotherapy
  • Cancer Immunotherapy / Immune-Oncology
  • Cancer Immunotherapy Associations
  • Advanced Immunotherapy and Cancer Immune System
  • Cancer Immunotherapy Students
  • Immunotherapy suppliers
  • Consulting companies
  • Exhibitors
  • Cancer Immunotherapy Analysts
  • Cancer Immunotherapy Associations and Societies
  • Immunologists
  • Rheumatologists
  • Microbiologists
  • Pulmonologists
  • Allergists
  • Pathologists
  • Clinical Immunologists
  • Physicians
  • Virologists
  • Biotechnologists
  • Immunology professionals

 

Tracks 1: Cancer Therapy

There are more than 300 types of cancer, including Breast cancer, cervical cancer, lung cancer, rectal cancer, Prostate cancer, and lymphoma. "Signs and Identification differs liable on the type of Cancer." Some people with cancer will have particular treatment. But most people have a synthesis of treatments, such as surgery with chemotherapy and/or acupuncture therapy. The Anticancer therapies include Palliative therapy, Immunotherapy, Hormonal therapy, Radiotherapy, Nutritional therapy, Phototherapy, Surgical therapy, Chemotherapy, Adjuvant therapy, Neoadjuvant therapy. Phototherapy is the most progressive among all the therapies. All Anticancer agents act by disturbing cell multiplication or normal functioning, DNA synthesis and by blocking or changing RNA and protein metabolite. Various therapies has been followed by the introduction of the new drug by clinical trials results, or by passing the cell under some radiations or radioactive waves or by taking some sort of medicine or considering with the alteration in the genetic material or by some sort of particular organ transplant.

  •  Surgical Therapy
  • Photodynamic Therapy
  • Hormonal Therapy
  • Palliative Therapy
  • Adjuvant Therapy

Tracks 2: Cancer Prevention & Research

Cancer Prevention is well-defined as active methods to reduction the risk of cancer. Most of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. An entity's risk of increasing cancer can be significantly reduced by healthy behaviour. Cancer Prevention Research embraces preclinical, clinical and translational research, with special attention given to molecular detection and an emphasis on building a translational bridge between the basic and clinical sciences.

  • Oncogenesis
  • Avoiding Risk Factors
  • Changing Lifestyle Choices
  • Preclinical & Clinical Research
  • Early Detection Research
  • Immunoprevention
  • Chemo preventive Measures

Track 3: Cancer Cell Biology & Genetics 

Cancer is caused when cells within the body accumulate genetic mutations and start to grow in an uncontrolled manner. Understanding how cancer develops and progresses, including how gene mutations drive the growth and spread of cancer cells, and how tumours interact with their surrounding environment, is vital for the discovery of new targeted cancer treatments.

  • Tumour Biology
  • Cancer Epigenetics
  • Oncogenes & Proto-oncogenes
  • Tumour Suppressor Genes

Track 4: Cancer Chemotherapy

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a healing intent, or it may aim to prolong life or to diminish symptoms.

  • Treatment strategies
  • Adverse effects
  • Limitations
  • Cancer Therapeutics, Novel and experimental approaches

Track 5: Cancer Immunology & Immunotherapy

Cancer immunology is a division of immunology that studies deals between the immune system and cancer cells. It is an arena of exploration that aims to ascertain cancer immunotherapies to treat and delay progression of the infection. Immunotherapies can be characterized as active, passive or hybrid (active and passive). The immune response, comprising the recognition of cancer-specific antigens, methods the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

  • Host-Tumor Relation
  • Cancer Immunosurveillance and Immunoediting
  • Clinical Cancer immunology
  • Cancer Antigens & Vaccines
  • Cellular Immunotherapy
  • Antibody Therapy
  • Cytokine Therapy
  • Combination & Combinatorial Ablation and Immunotherapies

Track 6 : Cancer Pharmacology

Cancer pharmacology plays an important role in medication development. In both the laboratory and the hospital, cancer pharmacology has had to adjust to the changing face of drug expansion by forming experimental representations and target orientated methods. It also emphases on developing new approaches to the clinical dealing of cancer over research that bridges the arenas of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It usually involves the pharmacological and oncological aspects of drugs at both.

  • Clinical Toxicology
  • Pharmacokinetics
  • Pharmacodynamics
  • Drug interactions
  • Cancer Drug Targets
  • Molecular Carcinogenesis
  • Biochemical Pharmacology
  • Clinical Pharmacology

Track 7: Cancer Diagnosis

Diagnostics plays an important role throughout Cancer treatment. Before treatment, to accurately locate Tumors, stage the disease, and determine an appropriate combination of cancer diagnosis. Diagnostics are used to track the size of the tumor, progression of the disease, and patient response to treatment, and modify your treatment accordingly. To confirm the diagnosis of most cancers, a liquid Biopsy needs is to be performed in which a tissue sample is removed from the tumor which occurred initially and studied under a microscope for detecting cancer cells. Endoscopy can be done by implanting a flexible plastic tube with a minute camera into body cavities or organs. Cancer Screening tests are used to detect the possibility of tumor cells which is present before symptoms occur. To identify cancer at its initial stage, different types of diagnostic tests are used to Screen at-risk individuals, Monitor treatment efficacy and disease progression or recurrence, Predict prognosis and direct treatment, Monitor an asymptomatic population for the early discovery of cancer, Earlier detection and treatment consequently drops cancer mortality, Diagnose a primary cancer and recognize the cancer .

Track 8: Clinical Oncology

Clinical Oncology embraces full range of Nonsurgical Cancers including the Chemotherapy, Radiotherapy, Palliative care and Biological targeted therapy. Clinical oncologists give Solid tumours with Chemotherapy, Conventional Radiotherapy, Brachytherapy, Biological therapy, Molecular targeted therapy and sometimes with multimodality trades that include the blend of two or more Anti-cancer therapies. Clinical oncologists regulate treatment by considering a range of aspects including tumour type, the site of the tumour, the stage of the disease and the patient’s general health. They then assess the relative merits of different diagnosis before presenting these to the patient so that an informed decision can be made. The branch also comprises the study of Cancer staging, Cancer epidemiology, Brachytherapy, Cancer biostatistics etc.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 9: Radiology and Imaging in Cancer

Radiology is the science used for the analysis and treatment of diseases inside the body with restaurant imagery. A range of imaging solutions is used to analyze or possibly treat diseases, e.g. x-rays, radiographs, ultrasound, recorded tomographic, nuclear pharmaceuticals, including positron discharge tomography (PET) and MRI. Medical imaging aims at revealing inner skin and bone structures and diagnosing and treating disease. Interventional radiology is the execution, with the aim of imaging innovations, of (normally negligible intricate) therapeutic methodology.

Session 10: Molecular Targeted Therapy

A modernized version of pharmacotherapy that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, unlike conventional chemotherapy that interferes with all rapidly dividing cells. Molecular Targeted Therapy is the expected to be a more effective method therapeutically and less harmful to the normal cells in the body. This particular session of the Cancer Treatment Conference shall emphasize on the targeted therapies for various types of cancers and how its effectiveness is greater compared to the rest of the conventional treatments.

 

Young Scientist Awards at Cancer Immunotherapy 2022 for the best researches in Cancer Immunotherapy.

Meetings International is announcing Young Scientist Awards through Cancer Immunotherapy Conference which is scheduled at Amsterdam, Netherlands during May 18-19, 2022. This Cancer Immunotherapy Conference focuses on Current Emerging Practices in Clinical and Experimental Cancer Immunotherapy.

Cancer Immunotherapy 2022 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Medical science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

Acknowledgement as YRF Awardee

Promotion on the conference website, Young Researcher Awards and certificates

Link on the conference website

Recognition on Meetings Int. Award Page

Chances to coordinate with partners around the world

Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Cancer Immunotherapy Conference.

 

The "Global Cancer Immunotherapy Market Analysis & Forecast to 2025" report has been added to Research And Markets.com's offering. Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about $75 billion in 2019 alone and are forecast to surpass $143 billion in 2025.This report describes the evolution of such a huge market in 20 chapters supported by over 180 tables and figures in 450 pages.

The global oncology information system market is estimated to occupy a large amount of revenue by recording a CAGR of ~7% during the forecast period, i.e., 2022 - 2030, owing to the increasing occurrence of cancer, and growing geriatric population around the world. Apart from these, government initiatives aimed at raising the demand for oncology information systems, and rising number of specific therapies in the oncology pipeline globally are also expected to drive market growth in the forthcoming years.

The market is segmented by product, software, and end user. Based on product, the software segment is anticipated to grab the largest market share during the forecast period on the back of surge in demand for coordinating treatment plans and keeping track of patient data. Additionally, by end user, the hospitals segment is projected to gather the largest share over the forecast period ascribing to the fact that large number of patients prefers hospital treatment, specifically in emerging nations, and growing procedural volume in hospital settings

The global cancer immunotherapy market size was valued at $85,603.50 million in 2020, and is projected to reach $309,667.65 million by 2030, registering a CAGR of 14.1% from 2021 to 2030.The COVID-19 pandemic has drastically affected buying capacity of hospitals, especially small-scale hospitals and scanning centers. According to an article by Cigna, there has been reductions in hospitalizations for non-elective conditions such as acute coronary syndromes and transient ischemic attacks that raise the possibility that patients may be deferring necessary elements of clinical care. The clinical trials of the new cancer immunotherapy drugs are kept on hold, as during this crisis the individual is more susceptible to suffer from COVID-19. COVID friendly cancer treatment however, are observed to be increased during the course of time and would propel in the coming years. Thus, the COVID-19 pandemic is anticipated to have a negative impact on the cancer immunotherapy market.

Cancer immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. This therapy is preferable than the old technique because it provides long-term cancer protection, has less side effects, and treats a wider range of cancer. Cancer immunotherapy is used in different types of cancers such as melanoma, prostate cancer, breast cancer, colorectal cancer, lung cancer, head & neck cancer, and more. Immunotherapy works by directing the immune system toward cancer-specific targets, activating the immune system to mobilize the target, and triggering a response capable of destroying cancer cells.

Reference

https://www.globenewswire.com/fr/news-release/2020/11/09/2122668/0/en/Global-Cancer-Immunotherapy-Market-Analysis-Forecast-to-2025.html 

https://www.marketwatch.com/press-release/global-oncology-information-system-market-growth-to-gain-momentum-by-a-cagr-of-7-throughout-2022---2030-on-the-back-of-increasing-incidences-of-cancer-across-the-globe-2021-10-27?tesla=y 

https://www.alliedmarketresearch.com/cancer-immunotherapy-market

Cancer Immunotherapy 2022 helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in Science and Medicine.

We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company. If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains. We maintain high quality and ethical standards of publication industry, which make us unique and better than the rest. Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals or relevant equipment or services, here is the opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide. Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations and high-level individuals, dedicated to host world class conferences and events. Meetings International supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry. Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator.

Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement. For further queries, connect our conference manager at sponsor@meetingsint.com

you can also connect us via WhatsApp: +65 3158 1626 / + 44 122980269

Google Analytics Metrics of  Cancer Immunotherapy 2022:

The visitor’s traffic is the benchmark for the success of conference and Infectious Diseases 2021 is constantly attracting viewers across the world.

According to the Google Analytics, more than 100+ monthly audiences are visiting to our conference websites for submitting abstracts; brochure downloads registration, exhibition and sponsorship queries.

Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

437,380 + Users

1,606,987 + Page views

644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers. The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.

  • Cancer Therapy
  • Cancer Prevention & Research
  • Cancer Cell Biology & Genetics
  • Cancer Chemotherapy
  • Cancer Immunology & Immunotherapy
  • Cancer Pharmacology
  • Cancer Diagnosis
  • Clinical Oncology
  • Radiology and Imaging in Cancer
  • Molecular Targeted Therapy

4 Organizing Committee Members